Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: flip side of the story

Inflamm Cell Signal. 2016;3(3):e1397. doi: 10.14800/ics.1397. Epub 2016 Aug 22.

Author

Yohannes T Ghebre¹

Affiliation

¹ Department of Radiation Oncology, Baylor College of Medicine, Houston, Texas 77030, USA.

No abstract available

Keywords: Antacid therapy; gastroesophageal reflux; idiopathic pulmonary fibrosis; pirfenidone; proton pump inhibitors.

Publication types

Comment

Grants and funding

K01 HL118683/HL/NHLBI NIH HHS/United States